These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17483512)

  • 1. Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent.
    Evison BJ; Mansour OC; Menta E; Phillips DR; Cutts SM
    Nucleic Acids Res; 2007; 35(11):3581-9. PubMed ID: 17483512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets.
    Evison BJ; Chiu F; Pezzoni G; Phillips DR; Cutts SM
    Mol Pharmacol; 2008 Jul; 74(1):184-94. PubMed ID: 18413664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation.
    Mansour OC; Evison BJ; Sleebs BE; Watson KG; Nudelman A; Rephaeli A; Buck DP; Collins JG; Bilardi RA; Phillips DR; Cutts SM
    J Med Chem; 2010 Oct; 53(19):6851-66. PubMed ID: 20860366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.
    Mansour OC; Nudelman A; Rephaeli A; Phillips DR; Cutts SM; Evison BJ
    Cancer Chemother Pharmacol; 2022 Jun; 89(6):773-784. PubMed ID: 35460360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and DNA sequence selectivity of formaldehyde-mediated DNA-adducts of the novel N-(4-aminobutyl) acridine-4-carboxamide.
    Ankers EA; Evison BJ; Phillips DR; Brownlee RTC; Cutts SM
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5710-5715. PubMed ID: 25453806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power and potential of doxorubicin-DNA adducts.
    Cutts SM; Nudelman A; Rephaeli A; Phillips DR
    IUBMB Life; 2005 Feb; 57(2):73-81. PubMed ID: 16036566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of DNA adducts by formaldehyde-activated mitoxantrone.
    Parker BS; Cullinane C; Phillips DR
    Nucleic Acids Res; 1999 Jul; 27(14):2918-23. PubMed ID: 10390534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts.
    Parker BS; Cutts SM; Cullinane C; Phillips DR
    Nucleic Acids Res; 2000 Feb; 28(4):982-90. PubMed ID: 10648792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
    Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron.
    Taatjes DJ; Gaudiano G; Koch TH
    Chem Res Toxicol; 1997 Sep; 10(9):953-61. PubMed ID: 9305576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
    Taatjes DJ; Fenick DJ; Koch TH
    J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent.
    Cutts SM; Rephaeli A; Nudelman A; Ugarenko M; Phillips DR
    Curr Top Med Chem; 2015; 15(14):1409-22. PubMed ID: 25866273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features.
    Pumuye PP; Evison BJ; Konda SK; Collins JG; Kelso C; Medan J; Sleebs BE; Watson K; Phillips DR; Cutts SM
    Bioorg Med Chem; 2020 Feb; 28(3):115260. PubMed ID: 31870833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.
    Spencer DM; Bilardi RA; Koch TH; Post GC; Nafie JW; Kimura K; Cutts SM; Phillips DR
    Mutat Res; 2008 Feb; 638(1-2):110-21. PubMed ID: 17961607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts.
    Ugarenko M; Nudelman A; Rephaeli A; Kimura K; Phillips DR; Cutts SM
    Biochem Pharmacol; 2010 Feb; 79(3):339-49. PubMed ID: 19737541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.
    Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G
    J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible and formaldehyde-mediated covalent binding of a bis-amino mitoxantrone analogue to DNA.
    Konda SK; Kelso C; Pumuye PP; Medan J; Sleebs BE; Cutts SM; Phillips DR; Collins JG
    Org Biomol Chem; 2016 May; 14(20):4728-38. PubMed ID: 27142235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for the formation of anthracycline-DNA adducts.
    Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
    Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase oxidizes mitoxantrone to metabolites which bind covalently to DNA and RNA.
    Panousis C; Kettle AJ; Phillips DR
    Anticancer Drug Des; 1995 Dec; 10(8):593-605. PubMed ID: 8595120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.